These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8004034)

  • 1. Contribution of "in vitro" assays to preclinical and premarketing testing in immunotoxicology.
    Procházková J
    Cent Eur J Public Health; 1993 Dec; 1(2):101-5. PubMed ID: 8004034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of the rat in developmental immunotoxicology studies.
    Chapin RE
    Hum Exp Toxicol; 2002; 21(9-10):521-3. PubMed ID: 12458910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present and future of in vitro immunotoxicology in drug development.
    Galbiati V; Mitjans M; Corsini E
    J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues with introducing new immunotoxicology methods into the safety assessment of pharmaceuticals.
    Dean JH
    Toxicology; 1997 Apr; 119(1):95-101. PubMed ID: 9129200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro techniques: can they replace animal testing?
    Pearson RM
    Hum Reprod; 1986 Dec; 1(8):559-60. PubMed ID: 3818914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles and practices of integrating genotoxicity evaluation into routine toxicology studies: a pharmaceutical industry perspective.
    Krishna G; Urda G; Theiss J
    Environ Mol Mutagen; 1998; 32(2):115-20. PubMed ID: 9776173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxicant screening and prioritization in the twenty-first century.
    Luebke R
    Toxicol Pathol; 2012; 40(2):294-9. PubMed ID: 22105646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests.
    Luster MI; Portier C; Pait DG; White KL; Gennings C; Munson AE; Rosenthal GJ
    Fundam Appl Toxicol; 1992 Feb; 18(2):200-10. PubMed ID: 1534777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the prospects for regulation in immunotoxicology?
    Hastings KL
    Toxicol Lett; 1998 Dec; 102-103():267-70. PubMed ID: 10022264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of drug-induced toxic effects on the immune system as assessed by proliferative assays and cytokine production.
    Pallardy M; Lebrec H; Blot C; Burleson GR; Bohuon C
    Eur Cytokine Netw; 1991; 2(3):201-6. PubMed ID: 1893072
    [No Abstract]   [Full Text] [Related]  

  • 11. The mouse as a model for developmental immunotoxicology.
    Holladay SD; Blaylock BL
    Hum Exp Toxicol; 2002; 21(9-10):525-31. PubMed ID: 12458911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxicology animal studies necessary for clinical research and registration of drugs for human use: conclusions of the International Harmonization Conference (I)].
    Rubio Terrés C; Duque I; Tristán C; Galende I
    Med Clin (Barc); 1993 Nov; 101(18):705-16. PubMed ID: 8114529
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo methods in immunotoxicology.
    Krakowka S
    Toxicol Pathol; 1987; 15(3):276-80. PubMed ID: 3685788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position of immunological techniques in screening in clinical toxicology.
    George S
    Clin Chem Lab Med; 2004; 42(11):1288-309. PubMed ID: 15576291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Assays of Hematopoietic Stem Cells in Toxicology Research.
    Laiosa MD
    Methods Mol Biol; 2018; 1803():317-333. PubMed ID: 29882147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental immunotoxicology and risk assessment: a workshop summary.
    Holsapple MP
    Hum Exp Toxicol; 2002; 21(9-10):473-8. PubMed ID: 12458903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended histopathology in immunotoxicity testing: interlaboratory validation studies.
    Germolec DR; Nyska A; Kashon M; Kuper CF; Portier C; Kommineni C; Johnson KA; Luster MI
    Toxicol Sci; 2004 Mar; 78(1):107-15. PubMed ID: 14691208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of animal studies in risk assessment for immunotoxicology.
    Luster MI; Portier C; Pait DG; Germolec DR
    Toxicology; 1994 Sep; 92(1-3):229-43. PubMed ID: 7940563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotoxicology: an overview.
    Dean JH; Thurmond LM
    Toxicol Pathol; 1987; 15(3):265-71. PubMed ID: 3317766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory forum opinion piece*: immunotoxicology assessments in nonhuman primates--challenges and opportunities.
    Lebrec HN
    Toxicol Pathol; 2013; 41(3):548-51. PubMed ID: 22886347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.